Prim (FRA:5P1) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:5P1 Prim SA FRA:5P1
76 GF Score
Price €12.95
GF Value €7.87
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Prim FFO per Share?

FFO per Share only applies to REITs.

FRA:5P1
76GF Score
Prim SA FRA:5P1
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Prim (FRA:5P1) Overvalued in 2026?

Based on GuruFocus' analysis, Prim stock appears to be overvalued. The current stock price of €12.95 is trading 64.5% above its estimated GF Value™ of €7.87. GuruFocus considers Prim to be Significantly Overvalued.

Key valuation signals for FRA:5P1:

  • FFO per Share:
  • GF Value™: €7.87 vs. price of €12.95 (64.5% above fair value)
  • GF Score™: 76/100 with 4 warning signs

No single metric tells the full story. See the FRA:5P1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Prim Business Description

Other Exchanges 0FP0:UKPRM:Spain
Address Calle F, numero 15, Poligono Industrial 1, Mostoles, Madrid, ESP, 28938
Prim SA is engaged in the provision of hospital supplies. The company is in a hospital and orthopedic supplies and materials for physiotherapy, thalassotherapy, thermal therapy, rehabilitation, geriatrics, as well as daily living aids. Prim work across a division of healthcare units such as Operating Theatres; Pain Management Centres; Plastic Surgery; Endosurgery and Cardiovascular.
76GF Score

Get the complete analysis for FRA:5P1

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€12.95
Price
€7.87
GF Value